DIMEN Medicina Nuclear
DIMEN Medicina Nuclear is a Brazilian specialty healthcare group operating since 1981 across 11 clinic units in São Paulo and Minas Gerais, providing PET/CT, scintigraphy, bone densitometry, radioisotope therapy, and radioguided surgery, while running an MEC-accredited nuclear medicine residency program.
- Company typePrivate
- Founded1981
- HeadquartersCampinas, Brazil
- Headcount101–250
- GTM typeB2C
- OfferingServices
What DIMEN Medicina Nuclear does
DIMEN Medicina Nuclear is a Brazilian nuclear medicine specialty group founded in 1981, headquartered in Campinas, Brazil, operating 11 clinic units across São Paulo and Minas Gerais states with 101-250 employees. The company provides diagnostic imaging and radiopharmaceutical therapy services centered on PET/CT (6 scanners), scintigraphy (14 Gamma Cameras), bone densitometry (3 DXA units), radioisotope therapy (including LU177-PSMA, 177Lu-DOTATATE, and 223-Ra for oncology), and radioguided surgery with Gamma Probe. DIMEN holds ISO 9001:2015 certification, ACSA International Accreditation, and runs an MEC-accredited 3-year medical residency program in Nuclear Medicine with an optional 4th-year PET/CT specialization, functioning as both a service provider and a training pipeline.
DIMEN's revenue model is professional-services based, billed primarily through Brazilian health insurance plans (convênios médicos) and out-of-pocket payments, with patients accessing services via 11 physical clinics, website scheduling, WhatsApp, or phone. The go-to-market combines direct-to-consumer patient scheduling with a physician-facing portal (PACS) for exam results and clinical case consultation, generating referrals from the medical community. The legal entity is DIMEN HOLDING E PARTICIPAÇÕES LTDA, with a core operating subsidiary (DIMEN - Camp Imagem Nuclear Ltda) running the residency program. The company is privately held with no disclosed external investors, funding rounds, M&A activity, or public listing.
DIMEN positions itself as a pioneering institution in Latin American nuclear medicine, having installed the first VariCam CoDe image transmission system in the region in 1998 and launched the first PET/CT with 18F-FDG in Brazil's interior. Marketing is conducted through the company website, social media (LinkedIn, YouTube, Instagram, Facebook), a monthly newsletter (DIMEN News), and clinical education webinars (DIMEN Talks). Operations are restricted to two Brazilian states, with no global footprint claim or international expansion evident in the available data.
DIMEN Medicina Nuclear firmographics
Firmographics- Name
- DIMEN Medicina Nuclear
- Legal name
- DIMEN HOLDING E PARTICIPAÇÕES LTDA
- Website
- https://dimen.com.br
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- DIMEN Medicina Nuclear is a Brazilian specialty healthcare group operating since 1981 across 11 clinic units in São Paulo and Minas Gerais, providing PET/CT, scintigraphy, bone densitometry, radioisotope therapy, and radioguided surgery, while running an MEC-accredited nuclear medicine residency program.
- Ownership category
- akta.pro rank
DIMEN Medicina Nuclear industry classification
Industry- Product category
- Nuclear Medicine Diagnostic Imaging
- NAICS
- Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)
- akta.pro secondary industries
- Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE), Therapeutic Radiopharmaceuticals (Radioligand/Targeted Radionuclide Therapy) (HLAIAGAB)
Keywords
Where DIMEN Medicina Nuclear is headquartered
LocationHeadquarters
- HQ city
- Campinas
- HQ country
- Brazil
- HQ region
- Latin America
Offices11 records
Markets served
DIMEN Medicina Nuclear business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Supply Chain, Marketing or Sales
Revenue model
- Diagnostic Imaging Services: Nuclear medicine diagnostic services including PET/CT, scintigraphy, and bone densitometry performed at 11 clinic units, billed through health insurance plans (convênios) or out-of-pocket
- Radioisotope Treatments: Therapeutic nuclear medicine procedures including radioiodine therapy for thyroid conditions, LU177-PSMA for prostate cancer, 177Lu-DOTATATE for neuroendocrine tumors, and 223-Ra for bone metastases
- Medical Education and Residency: Medical residency program in Nuclear Medicine accredited by MEC, contributing to training pipeline and institutional recognition
Go-to-market motion2 records
Distribution channels1 record
Marketing channels7 records
DIMEN Medicina Nuclear product offering
Product offeringCore offering
DIMEN Medicina Nuclear is a specialized healthcare provider operating since 1981, offering nuclear medicine diagnostic imaging and therapeutic services across 11 clinic units in the Brazilian states of São Paulo and Minas Gerais. Its core offerings include PET/CT hybrid imaging, scintigraphy (Gamma Camera), bone densitometry (DXA), radioisotope therapy for cancer and thyroid conditions, and radioguided surgery using a Gamma Probe. The company also runs an MEC-accredited medical residency program in Nuclear Medicine.
Product overview
DIMEN Medicina Nuclear is a specialized nuclear medicine company operating since 1981 across 11 units in São Paulo and Minas Gerais states, offering a portfolio of diagnostic imaging and radiopharmaceutical therapy services. The core diagnostic services include PET/CT (6 PETScan units), Scintigraphy (14 Gamma Cameras), and Bone Densitometry (3 DXA units), complemented by radioguided surgery with Gamma Probe. Therapeutic services center on Radioisotope Therapy for thyroid conditions, prostate cancer, and neuroendocrine tumors. Patient-facing digital services include an Online Results Portal and a Physician Portal for result access and clinical case management. DIMEN also operates a MEC-accredited 3-year Medical Residency Program in Nuclear Medicine with an optional 4th-year PET/CT focus. The company holds ISO 9001:2015 and ACSA international quality accreditations.
Differentiator
Problem solved
Functional benefit
Products and services
- PET/CT
Quantifiable outcome
- 44 years of operation since 1981
- +2 more outcomes
Companies that use DIMEN Medicina Nuclear
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
DIMEN Medicina Nuclear technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
DIMEN Medicina Nuclear partnerships and signals
Strategic signalScale indicators6 records
Expansion highlights6 records
DIMEN Medicina Nuclear competitors and assessment
Company assessmentOthers
- Siemens Healthineers: Global manufacturer of PET/CT scanners, SPECT gamma cameras, and molecular imaging IT used by DIMEN. Adjacent because it supplies the core capital equipment DIMEN depends on for both diagnostic imaging and radionuclide therapy workflows.
- Curium: Global nuclear medicine company producing diagnostic and therapeutic radiopharmaceuticals. Adjacent because it supplies radiotracers (e.g., Mo-99/Tc-99m, Lu-177-based therapies) that DIMEN relies on for its diagnostic and therapeutic offerings.
- Lantheus Holdings: Radiopharmaceutical-focused company with diagnostic imaging agents (including PyL for PSMA imaging) and therapeutic products. Adjacent as a supplier/ecosystem participant whose products underpin the theranostics market in which DIMEN operates.
- GE HealthCare: Global manufacturer of PET/CT, SPECT, and molecular imaging systems and radiopharmaceutical production equipment. Adjacent as a key supplier of DIMEN's imaging fleet and theranostics production technology.
Broad incumbents
- Grupo Fleury: One of Brazil's largest diagnostic medicine chains, offering laboratory, imaging, and nuclear medicine services across multiple states. Comparable because it offers PET/CT, scintigraphy, and radioisotope therapy as part of a broader portfolio competing for the same convênio-paid demand.
- DASA (Diagnósticos da América): Brazil's largest diagnostic medicine company, with an extensive outpatient imaging network including nuclear medicine. Overlaps with DIMEN in PET/CT and scintigraphy but operates at significantly greater scale and geographic breadth.
- CDB (Centro de Diagnósticos Brasil): Brazilian diagnostic imaging network with presence in São Paulo state. Overlaps with DIMEN in offering advanced imaging modalities and competing for the same convênio-reimbursed patient population in overlapping geographies.
- Alliar: Brazilian diagnostic chain with imaging centers across multiple states. Comparable because it provides outpatient imaging (including nuclear medicine-adjacent modalities) billed through convênios, competing for the same patient and physician referral base.
- Hospital Israelita Albert Einstein: Premier Brazilian hospital offering advanced nuclear medicine and PET/CT services. Comparable as a high-end nuclear medicine reference center competing for complex oncology imaging referrals in São Paulo, where DIMEN also operates.
- Rede D'Or São Luiz: Largest private hospital network in Brazil, operating extensive imaging and nuclear medicine services. Comparable because its hospital-based nuclear medicine units compete with DIMEN for complex imaging referrals in São Paulo and other major metros.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
DIMEN Medicina Nuclear social profiles
Digital presenceDIMEN Medicina Nuclear compliance and trust
Trust signalCompliance2 records
DIMEN Medicina Nuclear financial estimates
Financial estimateRevenue estimate
Valuation estimate
DIMEN Medicina Nuclear leadership team
Management profileNumber of profiles
Profiles9 records
DIMEN Medicina Nuclear subsidiaries and ownership
Company hierarchySubsidiaries1 record
DIMEN Medicina Nuclear funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
DIMEN Medicina Nuclear M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about DIMEN Medicina Nuclear
What does DIMEN Medicina Nuclear do?
DIMEN Medicina Nuclear is a specialized healthcare provider operating since 1981, offering nuclear medicine diagnostic imaging and therapeutic services across 11 clinic units in the Brazilian states of São Paulo and Minas Gerais. Its core offerings include PET/CT hybrid imaging, scintigraphy (Gamma Camera), bone densitometry (DXA), radioisotope therapy for cancer and thyroid conditions, and radioguided surgery using a Gamma Probe. The company also runs an MEC-accredited medical residency program in Nuclear Medicine.
Is DIMEN Medicina Nuclear a public or private company?
DIMEN Medicina Nuclear is a private company. It is classified as unknown and is currently operating.
When was DIMEN Medicina Nuclear founded?
DIMEN Medicina Nuclear was founded in 1981. It employs 101 to 250 people.
Where is DIMEN Medicina Nuclear based?
DIMEN Medicina Nuclear is headquartered in Campinas, Brazil, in the Latin America region.
How does DIMEN Medicina Nuclear make money?
Three revenue lines are on record. Diagnostic Imaging Services are the primary driver. The others are radioisotope Treatments and medical Education and Residency.
Who are DIMEN Medicina Nuclear's main competitors?
Others on record are Siemens Healthineers, Curium, Lantheus Holdings and GE HealthCare. Broad incumbents are Grupo Fleury, DASA (Diagnósticos da América), CDB (Centro de Diagnósticos Brasil), Alliar, Hospital Israelita Albert Einstein and Rede D'Or São Luiz.
Does DIMEN Medicina Nuclear have an API?
No public API is recorded for DIMEN Medicina Nuclear.
What industry is DIMEN Medicina Nuclear in?
DIMEN Medicina Nuclear's product category is Nuclear Medicine Diagnostic Imaging. Its primary akta.pro industry code is HLAIAGAI, Nuclear Medicine Clinical Services & Therapy Centers, with a secondary code of HLAHABAE, Nuclear Medicine & Molecular Imaging (SPECT/PET). Its NAICS code is 621512 and its SIC code is 8011.